Trial
NCT04061590
Pembrolizumab With or Without Chemotherapy Before Surgery in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of California, San Francisco
Collaborators
Merck Sharp & Dohme LLC
Condition
Lung Non-Small Cell Carcinoma
Intervention
Cisplatin
Why stopped
Low Accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-03-04